Bingshui Xiu

Title: Bingshui Xiu: Innovator in Medical Applications of Hyaluronic Acid

Introduction

Bingshui Xiu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine, particularly in the application of hyaluronic acid for treating various diseases. With a total of two patents to his name, his work is paving the way for innovative medical solutions.

Latest Patents

One of Bingshui Xiu's latest patents focuses on the application of hyaluronic acid in preparing medicines for preventing or treating ferroptosis-related diseases. This patent reveals the anti-ferroptosis function of hyaluronic acid, which is the first natural extracellular matrix material identified with such a function. Hyaluronic acid is abundant in the human body and is widely utilized in clinical settings.

His second patent involves a fusion imaging gene and lentiviral expression plasmid, which includes bioluminescence imaging genes, fluorescent protein genes, and calcium imaging genes. These genes are linked together and inserted into a modified lentiviral expression plasmid to create lentivirus particles that carry the fusion imaging gene.

Career Highlights

Bingshui Xiu has worked with esteemed organizations such as the Chinese Academy of Medical Sciences and Beijing Jiuyu Oncology Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical research.

Collaborations

Throughout his career, Bingshui Xiu has collaborated with notable colleagues, including Zhiqiang Liu and Zengqiang Yuan. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Bingshui Xiu's work exemplifies the intersection of innovation and medicine, particularly through his research on hyaluronic acid. His contributions are significant in the ongoing quest for effective treatments for ferroptosis-related diseases.